Monitoring of the SARS-CoV-2 Omicron BA.1/BA.2 lineage transition in the Swedish population reveals increased viral RNA levels in BA.2 cases
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
- Evaluated articles (Rapid Reviews Infectious Diseases)
Abstract
Article activity feed
-
-
Firdausi Qadri
Review 2: "Monitoring of the SARS-CoV-2 Omicron BA.1/BA.2 Variant Transition in the Swedish Population Reveals Higher Viral Quantity in BA.2 Cases"
In general, reviewers believe this preprint sets useful groundwork for future research, though somewhat lacking in explanation of the methods used to choose the analyzed sample and other details.
-
Jianfa Bai
Review 1: "Monitoring of the SARS-CoV-2 Omicron BA.1/BA.2 Variant Transition in the Swedish Population Reveals Higher Viral Quantity in BA.2 Cases"
In general, reviewers believe this preprint sets useful groundwork for future research, though somewhat lacking in explanation of the methods used to choose the analyzed sample and other details.
-
Strength of evidence
Reviewers: J Bai ( Kansas State University) | 📗📗📗📗◻️
F Qadri (International Centre for Diarrhoeal Disease Research, Bangladesh) | 📗📗📗📗◻️ -
SciScore for 10.1101/2022.03.26.22272984: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics Consent: Informed consent for the use of anonymized CT values or samples obtained in routine clinical diagnostics was not obtained and is not required, and is in accordance with the study permit obtained by the Swedish Ethical Review Authority (Dnr 2020-01945 and 2022-01139-02, Etikprövningsmyndigheten). Sex as a biological variable not detected. Randomization For the purpose and analyses of the current study, sample identities were anonymised, and IDs were replaced by a randomized code (i.e., those listed in supplementary tables). Blinding not detected. Power Analysis not detected. Table 2: Resources
Software and Algorithms Sentences Resources In the parallel genotyping of 133 SARS-CoV-2-positive … SciScore for 10.1101/2022.03.26.22272984: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics Consent: Informed consent for the use of anonymized CT values or samples obtained in routine clinical diagnostics was not obtained and is not required, and is in accordance with the study permit obtained by the Swedish Ethical Review Authority (Dnr 2020-01945 and 2022-01139-02, Etikprövningsmyndigheten). Sex as a biological variable not detected. Randomization For the purpose and analyses of the current study, sample identities were anonymised, and IDs were replaced by a randomized code (i.e., those listed in supplementary tables). Blinding not detected. Power Analysis not detected. Table 2: Resources
Software and Algorithms Sentences Resources In the parallel genotyping of 133 SARS-CoV-2-positive samples, performed using Thermo Fisher TaqMan SARS-CoV-2 Mutation Panel Assay (according to the manufacturers instructions) and our SARS-CoV-2 N1/RP/SBA1 assay, all Omicron samples were of the BA.1 lineage as demonstrated by WGS. Thermo Fisher TaqMansuggested: NoneWGSsuggested: NoneSARS-CoV-2 One-Step RT-PCR Kit, RdRp and N Genes, IVD (NZYTech) was performed according to the manufacturer’s instructions (Version 13/2021, December 2021). NZYTechsuggested: (NZYTech, RRID:SCR_016772)Sequencing data analysis: Raw data was quality trimmed using fastp10 v0.20.0 and de novo assembled using MEGAHIT11 v1.2.9 [--min-contig-len 5000] MEGAHIT11suggested: NoneDisjoint contigs were scaffolded against the SARS-CoV-2 reference genome [ASM985889v3] using RagTag12 v2.1.0 and SARS-CoV-2 lineage was assigned using pangolin13 v3.1.20 [lineages version 2022-02-28]. RagTag12suggested: NoneAlignment statistics was obtained using Minimap214 v2.24-r1122 [-ax sr Sars_cov_2.ASM985889v3.dna_sm.toplevel.fa.gz] and samtools15 v1.10 [stats] [coverage]. Minimap214suggested: Nonesamtools15suggested: NoneResults from OddPub: Thank you for sharing your code and data.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-